Raphas Co., Ltd. (KOSDAQ:214260)
9,820.00
-140.00 (-1.41%)
At close: Mar 31, 2026
Raphas Revenue
In the year 2025, Raphas had annual revenue of 30.99B KRW with 13.86% growth. Raphas had revenue of 6.21B in the quarter ending December 31, 2025, a decrease of -15.93%.
Revenue
30.99B
Revenue Growth
+13.86%
P/S Ratio
2.66
Revenue / Employee
392.25M
Employees
79
Market Cap
82.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.99B | 3.77B | 13.86% |
| Dec 31, 2024 | 27.22B | -720.52M | -2.58% |
| Dec 31, 2023 | 27.94B | 4.30B | 18.18% |
| Dec 31, 2022 | 23.64B | 3.30B | 16.22% |
| Dec 31, 2021 | 20.34B | 2.48B | 13.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Newtree | 98.91B |
| Icure Pharmaceutical Incorporation | 93.22B |
| KODI CO., LTD | 79.37B |
| Coreana Cosmetics | 73.68B |
| HuM&C | 52.00B |
| INSAN | 35.80B |
| Nowcos | 35.64B |
| TS Trillion | 27.95B |